# University Hospital Regensburg

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/university-hospital-regensburg/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 71.6 |
| Citations | 1,642,487 |
| City | Regensburg |
| Country | DE |
| Description | University Hospital Regensburg is a research organisation in Regensburg, DE. OpenAlex records 22,066 works and 1,642,487 citations for it. 5,573 researchers list it as their most recent affiliation. |
| Homepage | http://www.uniklinikum-regensburg.de/e/ |
| OpenAlex ID | https://openalex.org/I3129555431 |
| Researchers | 5,573 |
| ROR ID | https://ror.org/01226dv09 |
| Type | healthcare |
| Works | 22,066 |

## University papers

Showing 12 of 32.

- [A promoter-level mammalian expression atlas](https://scholariq.org/papers/a-promoter-level-mammalian-expression-atlas/)
- [Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS)](https://scholariq.org/papers/evidence-based-guidelines-on-the-therapeutic-use-of-repetitive-transcranial/)
- [Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS)](https://scholariq.org/papers/evidence-based-guidelines-on-the-therapeutic-use-of-transcranial-direct-current/)
- [Dermoscopy of pigmented skin lesions: Results of a consensus meeting via the Internet](https://scholariq.org/papers/dermoscopy-of-pigmented-skin-lesions-results-of-a-consensus-meeting-via-the/)
- [PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock](https://scholariq.org/papers/pci-strategies-in-patients-with-acute-myocardial-infarction-and-cardiogenic/)
- [Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial](https://scholariq.org/papers/lomustine-temozolomide-combination-therapy-versus-standard-temozolomide-therapy/)
- [Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration](https://scholariq.org/papers/complement-c3-inhibitor-pegcetacoplan-for-geographic-atrophy-secondary-to-age/)
- [One-Year Outcomes after PCI Strategies in Cardiogenic Shock](https://scholariq.org/papers/one-year-outcomes-after-pci-strategies-in-cardiogenic-shock/)
- [Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study](https://scholariq.org/papers/targeted-therapy-for-high-grade-glioma-with-the-tgf-2-inhibitor-trabedersen/)
- [Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma](https://scholariq.org/papers/sirolimus-use-in-liver-transplant-recipients-with-hepatocellular-carcinoma/)
- [Mitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular Therapy](https://scholariq.org/papers/mitochondrial-membrane-potential-identifies-cells-with-enhanced-stemness-for/)
- [Surgery for cholangiocarcinoma](https://scholariq.org/papers/surgery-for-cholangiocarcinoma/)

## University researchers

- [Thomas Betz](https://scholariq.org/researchers/thomas-betz/)

## University top topics

Showing 8 of 25.

- [Mechanical Circulatory Support Devices](https://scholariq.org/topics/mechanical-circulatory-support-devices/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Respiratory Support and Mechanisms](https://scholariq.org/topics/respiratory-support-and-mechanisms/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.